Lilly, New Mexico Settle Zyprexa Case For $15.5 Million

Not much to say about this, but New Mexico on Monday settled its claims that Eli Lilly had off-label marketed its antipsychotic Zyprexa for unapproved uses. New Mexico becomes the 39th state to reach some kind of financial settlement with the drugmaker over allegations concerning Zyprexa. Six more states have outstanding cases against Lilly. Lilly's total tab for Zyprexa settlements is now over $2.8 billion, by my estimate.